MACROGEN Inc.

42 articles with MACROGEN Inc.

• Macrogen Approved for Export of its COVID-19 Test Kit

  5/20/2020

  The Korean biotech company Macrogen (CEO Sukang Lee) (KOSDAQ: 038290), announced that it obtained export approval for COVID-19 test kit 'Axen TM COVID-19 RT' from the Ministry of Food and Drug Safety (MFDS) on the 18 th.

• Now, Get A Free Knock-out Mouse: The Improved Sperm-freezing Technology Enables Macrogen to Open the Overseas Genetically-Engineered Mice Market

  3/2/2020

  Macrogen, the Korean precision medicine biotech company, is hosting a ‘Now, Get A Free Knock-out Mouse!’ event on a first-come, first-served basis.

• Macrogen Signs License and Supply Agreement with Thermo Fisher Scientific

  1/13/2020

  Kap-Seok Yang, CEO of Macrogen, announced on January 13 that the company has signed a strategic License and Supply Agreement with Thermo Fisher Scientific.

• Macrogen: Successful Construction of the Largest Northeast Asian Reference Panel

  12/2/2019

  Reference panel expected to contribute to discover the Northeast Asian specific illness-related genes, and to develop tailored diagnosis method

• 

  10 Best Genome Sequencing Companies by Revenue

  11/29/2019

  The gene sequencing industry has really taken off in the years since the Human Genome Project. Look at these best genome sequencing companies in the world.

• Psomagen and Macrogen Granted U.S. Patent for Blockchain Data-sharing Technology

  9/17/2019

  Patent granted for blockchain technology for data transaction brokerage and sharing between data providers and users

• Macrogen Announces Strategic Investment in Australian Microbiome Company, Microba

  6/12/2019

  Share subscription agreement of 4.1million AUD with Microba

• Macrogen Receives GCLP Accreditation

  5/28/2019

  The precision medicine and biotechnology company, Macrogen announced on May 20 that it received GCLP accreditation from the Ministry of Food and Drug Safety in Korea.

• Macrogen and Exosome Plus to Jointly Develop Exosome-based Diagnostic and Treatment Solutions

  4/24/2019

  Contract signed for Macrogen to become the exclusive buyer of ‘Exosome Plus’ high-efficiency exosome isolation kit, ‘Exo2DTM’

• NRGene and Macrogen Launch Ultra-High-Density SNP Genotyping Service

  1/12/2019

  ArrayMAGIC is designed to provide convenient, cost-effective, and high-resolution genotyping

• Macrogen Becomes the First Clinical Lab in Korea to Receive CLIA Accreditation

  12/20/2018

  NGS labs in Seoul headquarters and Bundang Precision Medicine Center become the first in Korea to receive CLIA accreditation

• Macrogen Receives CAP Accreditation in Two Clinical Laboratories in Korea

  8/13/2018

  NGS Clinical Laboratories in Seoul headquarters and Bundang Precision Medicine Center Simultaneously Received the CAP Accreditation

• Macrogen Establishes Overseas Corporation in Singapore to Focus on Southeast Asian Market in Earnest

  6/5/2018

  Macrogen, Inc. announced on June 5 that it has established Macrogen Asia Pacific Pte. Ltd., a subsidiary in Singapore.

• Macrogen's Clinical NGS Laboratory Receives CAP Accreditation

  11/15/2017

  The accreditation was based on results of a recent on-site inspection as part of the CAP’s Accreditation Programs.

• MACROGEN Established Its Branch In Spain, Strengthening Localization Service In Europe

  9/5/2017

• MACROGEN Launches Special Promotion On Exome Sequencing To Celebrate Their 20th Anniversary

  6/2/2017

• MACROGEN Leads Precision Medicine By Advancing The Realization Of The "$100 Genome Age"

  3/28/2017

• MACROGEN Launches "Easybox", A Premium Temperature-Controlled Package

  9/13/2016

• MACROGEN Launches Famplan Genetic Carrier Testing, And ABOOBA Genetic Test For Newborns

  5/16/2016

• MACROGEN And National Cancer Center Korea Sign Business Agreement For Joint Research Into Genome Information-Based Precision Medicine With Cancer Patients

  4/27/2016